Delivery Order SPE2DB22D3501-SPE2DB23FXC44
Award Date 9/5/23
Potential Completion Date 9/6/23
Potential Value $2.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $23,505.87 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4 mg nasal spray naloxone hydrochloride. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location between September 6-7, 2023. The delivery order was issued under an existing DLA contract vehicle to supply an opioid overdose reversal medication in support of the agency's...
- The Defense Logistics Agency awarded a $2,287 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4 mg nasal spray naloxone hydrochloride. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract through its Conshohocken, Pennsylvania location. The delivery order was issued against an existing DLA contract vehicle to supply an opioid overdose reversal medication supporting DOD programs. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a $398 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561345174 Naloxone HCl 4mg nasal spray units. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform under the contract from its Conshohocken, Pennsylvania location from June 26-27, 2023. The delivery order was issued under an existing DLA contract vehicle to supply opioid overdose reversal medication in support of DOD programs....
- The Defense Logistics Agency awarded a $24,746.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4 mg nasal spray naloxone hydrochloride. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location between August 24-25, 2023. The delivery order was issued under an existing DLA contract vehicle to supply naloxone products in support of the Agency's medical...
- The Defense Logistics Agency awarded a $4,965 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 kits of 4mg nasal spray naloxone hydrochloride. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract through its Conshohocken, Pennsylvania location. The delivery order was issued against an existing DLA contract vehicle to supply opioid overdose reversal medication in support of DOD programs. No set aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,463 to Amerisourcebergen Drug Corporation to provide 4,562 units of 4mg Naloxone nasal spray. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract through its Conshohocken, Pennsylvania location. The period of performance is September 12-13, 2023. No major subcontractors or set aside designations were indicated. This order falls under...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $35,280 to Amerisourcebergen Drug Corporation for 4562336650 Naloxone HCL 4 MG nasal spray. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform under the contract from its Conshohocken, Pennsylvania location. The delivery order was issued on September 28, 2023 under an existing indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance...
- The Defense Logistics Agency awarded a $1,336 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 units of 4mg naloxone hydrochloride nasal spray. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract through its Conshohocken, Pennsylvania location. The delivery order was issued against an existing DLA contract vehicle to supply opioid overdose reversal medication in support of DOD programs. No...
- The Defense Logistics Agency awarded a $791 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561452976 units of 4mg Naloxone HCl nasal spray. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform under the contract from its Conshohocken, Pennsylvania location from July 10-11, 2023. The delivery order was issued under an existing DLA indefinite-delivery/indefinite-quantity vehicle, though further details were not...
- The Defense Logistics Agency awarded a $2,926.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 boxes of 4mg Naloxone nasal spray. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is September 12-13, 2023. This order was placed under an existing DLA contract vehicle to supply opioid overdose reversal medication in support of the agency's medical readiness programs. As the prime contractor,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FXC44Delivery Order
The Defense Logistics Agency awarded a $2,436.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4 mg naloxone hydrochloride nasal spray kits. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location between September 5-6, 2023. The delivery order was issued under an existing DLA contract vehicle to supply opioid overdose reversal medication in support of the agency's medical readiness programs. No set aside provisions or subcontractors were identified.
Generated 12/16/23, 10:01 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/5/23 |